Department of Medicine, Veterans Affairs Boston Healthcare System, Boston, Massachusetts, USA.
Infect Control Hosp Epidemiol. 2012 Nov;33(11):1113-7. doi: 10.1086/668026. Epub 2012 Sep 19.
In the absence of established methicillin-resistant Staphylococcus aureus (MRSA) screening programs, many centers use a history of a positive culture or a nasal screen as a surrogate for preoperative MRSA colonization status. We aimed to evaluate the test characteristics of these surrogates.
Retrospective cohort study.
Veterans Affairs Boston Healthcare System surgical patients with a preoperative nasal MRSA polymerase chain reaction (PCR) screen.
We assessed the performance of a history of a MRSA-positive culture or a positive nasal MRSA PCR screen during the year prior to surgery for predicting the preoperative nasal PCR screen result. The associations between MRSA history and postoperative outcomes, including MRSA cultures and infections, were also evaluated.
Among 4,238 patients, a positive MRSA culture history had a sensitivity of 19.7% (95% confidence interval [CI], 15.4%-24.8%) and positive predictive value of 57.3% for the preoperative nasal MRSA status. The specificity of MRSA culture history was 99% (95% CI, 98.5%-99.2%). Prior-year nasal MRSA screen results had similar test characteristics. A history of a MRSA-positive culture was associated with an increased risk of postoperative MRSA-positive cultures (risk ratio [RR], 3.54 [95% CI, 1.70-7.37], [Formula: see text]) but not of infections (RR, 1.71 [95% CI, 0.58-5.01]), after adjustment for preoperative nasal MRSA status, vancomycin surgical prophylaxis, surgical scrub, and age.
A history of a MRSA-positive culture and a positive nasal PCR screen are poor surrogate markers of preoperative colonization status, missing at least 70% of MRSA-colonized patients. Prior-year history is also not independently associated with MRSA-related postoperative infections. Strong consideration should be given to preoperative MRSA screening in patients at high risk for surgical complications.
在缺乏既定的耐甲氧西林金黄色葡萄球菌(MRSA)筛查计划的情况下,许多中心将阳性培养史或鼻腔筛查作为术前 MRSA 定植状态的替代指标。我们旨在评估这些替代指标的检测特征。
回顾性队列研究。
退伍军人事务部波士顿医疗保健系统接受术前鼻腔 MRSA 聚合酶链反应(PCR)筛查的手术患者。
我们评估了术前一年中 MRSA 阳性培养史或阳性鼻腔 MRSA PCR 筛查史对预测术前鼻腔 PCR 筛查结果的表现。还评估了 MRSA 病史与术后结果(包括 MRSA 培养和感染)之间的关联。
在 4238 例患者中,MRSA 阳性培养史的敏感性为 19.7%(95%置信区间[CI],15.4%-24.8%),对术前鼻腔 MRSA 状态的阳性预测值为 57.3%。MRSA 培养史的特异性为 99%(95%CI,98.5%-99.2%)。前一年的鼻腔 MRSA 筛查结果具有相似的检测特征。MRSA 阳性培养史与术后 MRSA 阳性培养物的风险增加相关(风险比[RR],3.54[95%CI,1.70-7.37],[公式:见文本]),但与感染无关(RR,1.71[95%CI,0.58-5.01]),在调整术前鼻腔 MRSA 状态、万古霉素手术预防、手术擦洗和年龄后。
MRSA 阳性培养史和阳性鼻腔 PCR 筛查是术前定植状态的较差替代标志物,至少漏诊了 70%的 MRSA 定植患者。前一年的病史也与 MRSA 相关的术后感染无关。对于有手术并发症高风险的患者,应强烈考虑进行术前 MRSA 筛查。